Govt panel has approved phase-3 study of Covovax as booster dosage
Official sources informed PTI on Sunday, March 6, that an expert panel of India’s federal drug regulator has recommended clearance for a phase-3 clinical study of COVID-19 vaccine Covovax as a booster dose in adults. On December 28, the Drugs Controll...
7 March, 2022
Read more